Quantcast
Environmental News for a Healthier Planet and Life

Help Support EcoWatch

Monsanto Roundup Cancer Trial Postponed in St. Louis, Bayer Stock Climbs

Health + Wellness
The compound of German chemicals and pharmaceuticals giant Bayer in Berlin on March 20, 2019. ODD ANDERSEN / AFP via Getty Images

By Carey Gillam

A highly anticipated Roundup cancer trial set to start later this month in the St. Louis area has been pulled from the docket, a court official said on Wednesday.


The trial, which was to pit a woman named Sharlean Gordon against Roundup maker Monsanto Co., was to start Jan. 27 in St. Louis County and was to be broadcast to the public. Notably, Gordon's lawyers planned to put former Monsanto CEO Hugh Grant on the stand. St. Louis was the home of Monsanto's corporate headquarters until the company was purchased by Bayer AG of Germany in June of 2018.

In taking the trial off the calendar, the judge in the case has ordered that a status conference be set for a month from now, said St. Louis County Court spokeswoman Christine Bertelson.

The Gordon trial was already postponed once – it originally was scheduled for August. It is one of several trials that have been postponed in the last several months as Bayer attempts to find a settlement to the mass of claims filed against Monsanto by people stricken with non-Hodgkin lymphoma they claim was caused by exposure to Monsanto Roundup and other glyphosate-based herbicides. Bayer officials have said that Monsanto is facing more than 42,700 plaintiffs in the U.S.

Gordon developed non-Hodgkin lymphoma after using Roundup herbicides for 25 years at her residence in South Pekin, Illinois, and has suffered extensive debilitation due to her disease. Gordon's stepfather, who also used Roundup at the family home, died of cancer. The case is actually derived from a larger case filed in July 2017 on behalf of more than 75 plaintiffs. Gordon was to be the first of that group to go to trial.

Monsanto and Bayer have denied that Monsanto's herbicides can cause cancer, and assert the litigation is without merit but is being fueled by greedy plaintiffs' attorneys.

According to sources close to the litigation, discussions are underway to postpone more Roundup cancer trials, possibly including one set to start Jan. 21 in St. Louis City Court. Attorneys for Monsanto and for the plaintiffs in the upcoming January trials declined to comment.

Shares in Bayer hit a 52-week high and were up close to 3 percent Wednesday. Investors have been pushing the company to find a way to avoid future trials and to settle the litigation.

In the three Roundup cancer trials held so far, unanimous juries have found that exposure to Monsanto's herbicides does cause non-Hodgkin lymphoma and that the company covered up the risks and failed to warn consumers. The three juries awarded a total of four plaintiffs more than $2 billion in damages, but the trial judges in each case have reduced the awards significantly.

No damages have yet been paid as Monsanto appeals the verdicts.

Bayer's annual shareholders' meeting is set for April 28 and analysts said investors would like to see either a settlement of the litigation by that time, or at least meaningful progress in containing the liability. Bayer's stock took a dive, losing billions of dollars in value, after the first jury verdict in August 2018, and share prices remain depressed.

Reposted with permission from U.S. Right to Know.

EcoWatch Daily Newsletter

More than 1,000 people were told to evacuate their homes when a wildfire ignited in the foothills west of Denver Monday, Colorado Public Radio reported.

Read More Show Less

Accessibility to quality health care has dropped for millions of Americans who lost their health insurance due to unemployment. mixetto / E+ / Getty Images

Accessibility to quality health care has dropped for millions of Americans who lost their health insurance due to unemployment. New research has found that 5.4 million Americans were dropped from their insurance between February and May of this year. In that three-month stretch more Americans lost their coverage than have lost coverage in any entire year, according to The New York Times.

Read More Show Less
Heat waves are most dangerous for older people and those with health problems. Global Jet / Flickr / CC by 2.0

On hot days in New York City, residents swelter when they're outside and in their homes. The heat is not just uncomfortable. It can be fatal.

Read More Show Less
Nearly 250 U.S. oil and gas companies are expected to file for bankruptcy by the end of next year. Joshua Doubek / Wikimedia Commons / CC by 3.0

Fracking companies are going bankrupt at a rapid pace, often with taxpayer-funded bonuses for executives, leaving harm for communities, taxpayers, and workers, the New York Time reports.

Read More Show Less
Trump introduces EPA Administrator Andrew Wheeler during an event to announce changes to the National Environmental Policy Act, in the Roosevelt Room of the White House on Jan. 9, 2020 in Washington, DC. The changes would make it easier for federal agencies to approve infrastructure projects without considering climate change. Drew Angerer / Getty Images

A report scheduled for release later Tuesday by Congress' non-partisan Government Accountability Office (GAO) finds that the Trump administration undervalues the costs of the climate crisis in order to push deregulation and rollbacks of environmental protections, according to The New York Times.

Read More Show Less
The American Federation of Teachers (AFT), National Education Association (NEA), and AASA, The School Superintendents Association, voiced support for safe reopening measures. www.vperemen.com / Wikimedia Commons / CC-BY-SA

By Kristen Fischer

It's going to be back-to-school time soon, but will children go into the classrooms?

The American Academy of Pediatrics (AAP) thinks so, but only as long as safety measures are in place.

Read More Show Less

Trending

Critics charge the legislation induces poor communities to sell off their water rights. Pexels

By Eoin Higgins

Over 300 groups on Monday urged Senate leadership to reject a bill currently under consideration that would incentivize communities to sell off their public water supplies to private companies for pennies on the dollar.

Read More Show Less